CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-29 | Lackey Melinda Legal & Administration | Grant or award · Employee Stock Option (right to buy) | +1,000 | 1,000 | ||
| 2025-03-29 | Groenewald Ferdinand VP, Finance | Grant or award · Employee Stock Option (right to buy) | +3,000 | 3,000 | ||
| 2024-12-31 | Vieser Jaime Director | Sale | −2,182 | $2.01 | $4K | 26,712 |
| 2024-12-31 | Vieser Jaime Director | Sale | −818 | $2.00 | $2K | 25,894 |
| 2024-08-14 | Groenewald Ferdinand VP, Finance | Grant or award · Employee Stock Option (right to buy) | +1,500 | 1,500 | ||
| 2024-08-14 | Lackey Melinda Legal & Administration | Grant or award · Employee Stock Option (right to buy) | +1,500 | 1,500 | ||
| 2024-06-06 | Weis Holger Director | Grant or award · Employee Stock Option (right to buy) | +19,200 | 19,200 | ||
| 2024-06-06 | Weis Holger Director | Grant or award · Employee Stock Option (right to buy) | +4,524 | 4,524 | ||
| 2024-06-06 | Vieser Jaime Director | Grant or award · Employee Stock Option (right to buy) | +12,800 | 12,800 | ||
| 2024-06-06 | Postma Robert W Director | Grant or award · Employee Stock Option (right to buy) | +12,800 | 12,800 | ||
| 2024-06-06 | Hofmeister Robert Director | Grant or award · Employee Stock Option (right to buy) | +12,800 | 12,800 | ||
| 2024-01-20 | Hogue Dale Curtis Jr. Interim CEO | Grant or award · Employee Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2023-12-29 | Hogue Dale Curtis Jr. Director | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-12-29 | Hogue Dale Curtis Jr. Director | Grant or award · Employee Stock Option (right to buy) | +41,667 | 41,667 | ||
| 2023-09-01 | Boyle Kevin S. Sr. Chief Executive Officer | Sale 10b5-1 | −68,014 | $0.14 | $10K | 798,236 |
| 2023-06-06 | Postma Robert W Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-06-06 | Hofmeister Robert Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-06-06 | Thistle Mary Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-06-06 | Huang James Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-06-06 | Vieser Jaime Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 |
Page 3 of 16 · 304 trades